Providence Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Buy |
+135
| New | +$17.1K | ﹤0.01% | 184 |
|
|
2024
Q4 | – | Sell |
-135
| Closed | -$19.7K | – | 210 |
|
|
2024
Q3 | $19.7K | Hold |
135
| – | – | ﹤0.01% | 218 |
|
|
2024
Q2 | $18.5K | Hold |
135
| – | – | ﹤0.01% | 209 |
|
|
2024
Q1 | $18.5K | Hold |
135
| – | – | ﹤0.01% | 207 |
|
|
2023
Q4 | $18.3K | Sell |
135
-50
| -27% | -$6.79K | ﹤0.01% | 217 |
|
|
2023
Q3 | $22.6K | Hold |
185
| – | – | 0.01% | 200 |
|
|
2023
Q2 | $23.5K | Hold |
185
| – | – | 0.01% | 184 |
|
|
2023
Q1 | $23.9K | Hold |
185
| – | – | 0.01% | 180 |
|
|
2022
Q4 | $24.3K | Hold |
185
| – | – | 0.01% | 173 |
|
|
2022
Q3 | $22K | Hold |
185
| – | – | 0.01% | 175 |
|
|
2022
Q2 | $22K | Hold |
185
| – | – | 0.01% | 180 |
|
|
2022
Q1 | $24K | Hold |
185
| – | – | 0.01% | 205 |
|
|
2021
Q4 | $28K | Hold |
185
| – | – | 0.01% | 181 |
|
|
2021
Q3 | $30K | Hold |
185
| – | – | 0.01% | 174 |
|
|
2021
Q2 | $30K | Hold |
185
| – | – | 0.01% | 165 |
|
|
2021
Q1 | $28K | Hold |
185
| – | – | 0.01% | 164 |
|
|
2020
Q4 | $28K | Buy |
+185
| New | +$28K | 0.01% | 169 |
|
|
2020
Q1 | – | Sell |
-15
| Closed | -$2K | – | 274 |
|
|
2019
Q4 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 238 |
|
|
2018
Q4 | – | Sell |
-175
| Closed | -$21K | – | 263 |
|
|
2018
Q3 | $21K | Buy |
+175
| New | +$21K | 0.01% | 167 |
|
|
2018
Q1 | – | Sell |
-33
| Closed | -$4K | – | 278 |
|
|
2017
Q4 | $4K | Buy |
+33
| New | +$4K | ﹤0.01% | 275 |
|